iohexol has been researched along with Hyperthyroidism in 8 studies
Iohexol: An effective non-ionic, water-soluble contrast agent which is used in myelography, arthrography, nephroangiography, arteriography, and other radiographic procedures. Its low systemic toxicity is the combined result of low chemotoxicity and low osmolality.
iohexol : A benzenedicarboxamide compound having N-(2,3-dihydroxypropyl)carbamoyl groups at the 1- and 3-positions, iodo substituents at the 2-, 4- and 6-positions and an N-(2,3-dihydroxypropyl)acetamido group at the 5-position.
Hyperthyroidism: Hypersecretion of THYROID HORMONES from the THYROID GLAND. Elevated levels of thyroid hormones increase BASAL METABOLIC RATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Absorbed thyroid dose and effective half-life were determined in 46 hyperthyroid cats after treatment with a low dose (mean 111MBq) of radioiodine intravenously." | 7.74 | Interference of iohexol with radioiodine thyroid uptake in the hyperthyroid cat. ( Bacher, K; Daminet, S; Peremans, K; van Hoek, I; Vandermeulen, E; Vermeire, S, 2008) |
| "The study investigated plasma clearance of exogenous creatinine (PECCT), exo-iohexol (PexICT) and endo-iohexol (PenICT) in six healthy cats, four cats with chronic kidney disease (CKD) and six hyperthyroid (HT) cats to assess potential differences in glomerular filtration rate (GFR) measurement over a wide range of GFR values." | 3.75 | Comparison of plasma clearance of exogenous creatinine, exo-iohexol, and endo-iohexol over a range of glomerular filtration rates expected in cats. ( Biourge, V; Croubels, S; Daminet, S; Lefebvre, HP; Paepe, D; van Hoek, IM, 2009) |
| "Absorbed thyroid dose and effective half-life were determined in 46 hyperthyroid cats after treatment with a low dose (mean 111MBq) of radioiodine intravenously." | 3.74 | Interference of iohexol with radioiodine thyroid uptake in the hyperthyroid cat. ( Bacher, K; Daminet, S; Peremans, K; van Hoek, I; Vandermeulen, E; Vermeire, S, 2008) |
| "We conclude that before administration of iodine-containing contrast agent for ERCP in patients without a history of thyroid disease, thyroid ultrasonographic examination, rather than TSH measurements, should be performed, in order to identify patients already at risk for hyperthyroidism before diagnostic enteral contrast-medium application." | 3.71 | Thyroid function, thyroid immunoglobulin status, and urinary iodine excretion after enteral contrast-agent administration by endoscopic retrograde cholangiopancreatography. ( Bretzel, RG; Doppl, W; Fassbender, WJ; Klör, HU; Stracke, H; Vogel, C, 2001) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Özkan, S | 1 |
| Oysu, AS | 1 |
| Kayataş, K | 1 |
| Demirtunç, R | 1 |
| Eren, M | 1 |
| Uslu, H | 1 |
| Altuntaş, Y | 1 |
| Peremans, K | 1 |
| Vandermeulen, E | 1 |
| van Hoek, I | 1 |
| Daminet, S | 2 |
| Vermeire, S | 1 |
| Bacher, K | 1 |
| van Hoek, IM | 1 |
| Lefebvre, HP | 1 |
| Paepe, D | 1 |
| Croubels, S | 1 |
| Biourge, V | 1 |
| Brzozowski, K | 1 |
| Piasecki, P | 1 |
| Zięcina, P | 1 |
| Frankowska, E | 1 |
| Jaroszuk, A | 1 |
| Kamiński, G | 1 |
| Bogusławska-Walecka, R | 1 |
| Saam, T | 1 |
| Hess, T | 1 |
| Kasperk, C | 1 |
| Kauffmann, GW | 1 |
| Düx, M | 1 |
| Nygaard, B | 1 |
| Nygaard, T | 1 |
| Jensen, LI | 1 |
| Court-Payen, M | 1 |
| Søe-Jensen, P | 1 |
| Nielsen, KG | 1 |
| Fugl, M | 1 |
| Hansen, JM | 1 |
| Fassbender, WJ | 2 |
| Vogel, C | 1 |
| Doppl, W | 1 |
| Stracke, H | 2 |
| Bretzel, RG | 2 |
| Klör, HU | 1 |
| Schlüter, S | 1 |
| Waas, W | 1 |
| Tillmanns, H | 1 |
8 other studies available for iohexol and Hyperthyroidism
| Article | Year |
|---|---|
Thyroid functions after contrast agent administration for coronary angiography: a prospective observational study in euthyroid patients.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Coronary Angiography; Female; Humans; Hyperthyroidis | 2013 |
Interference of iohexol with radioiodine thyroid uptake in the hyperthyroid cat.
Topics: Animals; Cat Diseases; Cats; Contrast Media; Drug Interactions; Female; Glomerular Filtration Rate; | 2008 |
Comparison of plasma clearance of exogenous creatinine, exo-iohexol, and endo-iohexol over a range of glomerular filtration rates expected in cats.
Topics: Analysis of Variance; Animals; Cat Diseases; Cats; Creatinine; Female; Glomerular Filtration Rate; H | 2009 |
Partial thyroid arterial embolization for the treatment of hyperthyroidism.
Topics: Adult; Aged; Aged, 80 and over; Angiography, Digital Subtraction; Contrast Media; Embolization, Ther | 2012 |
[Prevalence of latent and manifest hyperthyroidism in an iodine-deficient area: non-selected patient population admitted for CT studies with iodine-containing contrast agents].
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Germany; Humans; Hyperthyroidism; Iohexol; Middle Ag | 2005 |
Iohexol: effects on uptake of radioactive iodine in the thyroid and on thyroid function.
Topics: Adult; Aged; Aged, 80 and over; Contrast Media; Female; Follow-Up Studies; Humans; Hyperthyroidism; | 1998 |
Thyroid function, thyroid immunoglobulin status, and urinary iodine excretion after enteral contrast-agent administration by endoscopic retrograde cholangiopancreatography.
Topics: Administration, Oral; Autoantibodies; Cholangiopancreatography, Endoscopic Retrograde; Contrast Medi | 2001 |
[Thyroid function after iodine-containing contrast agent administration in coronary angiography: a prospective study of euthyroid patients].
Topics: Angioplasty, Balloon, Coronary; Autoantibodies; Cardiac Catheterization; Contrast Media; Coronary An | 2001 |